Aimed at accommodating the rapid growth of Oxford’s Science & Technology companies, the construction of the latest state of the art office and advanced R&D laboratory hybrid building is underway. Building 7 is the third in a collection of innovative high...
Planning permission has been secured for a new phase of development at Oxford Technology Park, providing the opportunity to build the much needed lab-space for the life science sector in the county. Cherwell District Council have approved plans with an...
Life Science REIT (AIM: LABS), the real estate investment trust focused on UK life science properties has completed the acquisition of Oxford Technology Park (“OTP”), a 20 acre science and technology park which, once fully developed, will comprise up to 450,000 sq ft...
The construction of an impressive high-tech purpose-built R&D and manufacturing facility, which will be a vital hub for one of the world’s leading suppliers of reagents enabling research into diagnostics and vaccines for emerging and endemic infectious diseases,...
The Native Antigen Company, one of the world’s leading suppliers of infectious disease antigens and antibodies, has signed a pre-let for a new purpose-built R&D and manufacturing facility at the Oxford Technology Park. It follows the acquisition of The Native...